Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check7 days agoChange DetectedAdded a Show glossary option and updated labels to Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a consolidated Locations section listing study sites in Arizona, California, Florida, Georgia, Iowa, Missouri, Ohio, Oregon, Pennsylvania, and Washington. Removed individual location subsections (Arizona Locations, California Locations, etc.) and updated the page footer to Revision: v3.3.3.SummaryDifference1%

- Check64 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's footer revision tag changed from v3.2.0 to v3.3.1; this is a minor metadata update and does not affect content or features.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved a government funding status notice that stated potential delays; core study information such as title, conditions, locations, and outcomes remains unchanged.SummaryDifference0.4%

- Check93 days agoChange DetectedThe latest screenshot shows cosmetic/layout updates to the study page, with sections and navigation reorganized but all substantive content (dates, enrollment, inclusion/exclusion criteria, outcomes, and locations) remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.